Calcitonin gene-related peptide receptor antagonist ubrogepant for the treatment of acute migraine: A meta-analysis

BACKGROUND: The objective of this study is to systematically evaluate the efficacy and safety of the calcitonin gene-related peptide (CGRP) receptor antagonist ubrogepant for the treatment of acute migraine. METHODS: Randomized controlled trials (RCTs) of ubrogepant for treatment of acute migraine w...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zizhen, Shu, Yunfeng, Diao, Yun, Du, Yang, Chen, Lizhi, Liu, Ying, Du, Biao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909234/
https://www.ncbi.nlm.nih.gov/pubmed/33663087
http://dx.doi.org/10.1097/MD.0000000000024741

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909234/
https://www.ncbi.nlm.nih.gov/pubmed/33663087
http://dx.doi.org/10.1097/MD.0000000000024741

Ejemplares similares